Drug biggie GlaxoSmithKline has been slapped with another huge settlement for its questionable marketing tactics. This time, the pharma company has agreed to pay $105 million to resolve claims made by attorneys general from 45 states regarding the selling of asthma drug Advair and antidepressants Paxil and Wellbutrin. [More]
